Systemic Adjuvant Therapy for Patient at High Risk for Recurrent Melanoma

A clinical practice guideline for adult patients with resected melanoma at high risk for recurrence. The guideline examines systemic therapy options, specifically with interferon, and highlights the importance of novel therapeutic trials. Outcomes of interest include improved melanoma staging and improved event-free survival.